The purpose of this study is to see if there is benefit to using an IV contrast called AK-Fluor® and a microscope filter called YELLOW560 when surgically removing a vestibular schwannoma, Meningioma, Head and Neck Paraganglioma, or Head and Neck Schwannoma.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
12
Intravenous administration 1 mg/kg initial dosing if insufficient additional doses of 1 mg/kg may be administered.
Integrated fluorescence module serves to make fluorescent areas visible to assist in visualizing tumor during the resection.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Surgeon Predicted Use of Fluorescein Sodium in Future Cases
Physician response to surgeon survey question, "Based on the use and performance of FS in this case alone, how likely are you to use FS in future cases (excluding the research trial) involving this tumor?" using a Likert-style rating from 0-4 where 0=Unsure; 1= Plan to not use in any cases; 2= Plan to use in select cases; 3=Plan to use in the majority of cases; 4=Plan to use in all cases.
Time frame: Approximately 3 months postoperatively
Correlation of Fluorescein Sodium With Surgeons' Visual Assessment
Fluorescence correlate with surgeons' visual assessment of the tumor and nerve tissue under normal microscopy without the Yellow 560 filter using a Likert-style rating from 1-4 where 1=No correlation; 2=Some correlation; 3=Good correlation; 4=Excellent correlation.
Time frame: Intraoperatively, approximately 1 day
Correlation of Fluorescein Sodium With Electrostimulation
Surgeons' assessment of fluorescence correlate with electrostimulation (e.g. tissues with high fluorescence do not stimulate, whereas nerve tissues with low fluorescence do stimulate)" using a Likert-style rating from 1-4 where 1=No correlation; 2=Some correlation; 3=Good correlation; 4=Excellent correlation.
Time frame: Intraoperatively, approximately 1 day
Time to Differential Visualization
The amount of time in minutes for differential visualization of the tumor and surrounding tissue after sodium fluorescein administration during surgery
Time frame: Intraoperatively, approximately 1 day
Average Dose of Sodium Fluorescein Administration
Average dose of sodium fluorescein administered during surgery to achieve differential fluorescence of the tumor and tissue reported in mg/kg
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Intraoperatively, approximately 1 day
Total Resection Rate
Number of subjects to have a gross total resection
Time frame: Intraoperatively, approximately 1 day